Search Within

Dmitriy Zamarin

  1. "2013"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (6)
  2. GDMT, Medicine (6)
  3. Gynecologic Medicine Service (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. GSK Faculty (4)

More Groups

People
  1. Jedd Wolchok (4)
  2. Rikke Holmgaard (4)
  3. James Allison (3)
  4. Alexander Lesokhin (2)
  5. Danielle Chimento (2)
  6. David Chung (2)

More People

Years
  1. 2013 (6)
Publications
  1. Journal for ImmunoTherapy of Cancer (2)
  2. Bone Marrow Transplantation (1)
  3. Journal of Experimental Medicine (1)
  4. Journal of Immunology (1)
  5. Leukemia (1)
Publishers
  1. Biomed Central Ltd (2)
  2. Nature Publishing Group (2)
  3. Rockefeller University Press (1)
  4. The American Association of Immunologists, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
    Meeting Abstract

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
    Meeting Abstract

    Zamarin, D.; Holmgaard, R.; Subudhi, S.; Mansour, M.; Palese, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase and T-cell based anti-tumor immunotherapies targeting immune checkpoints
    Meeting Abstract

    Holmgaard, R.; Zamarin, D.; Munn, D.; Wolchok, J.; Allison, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Munn, D. H.; Wolchok, J. D.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
    Journal Article

    Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save